MedTrace Logo

Prevention of Shivering Associated With Spinal Anesthesia

NCT06082076 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-10-13

No results posted yet for this study

Summary

The aim of the study is to compare the effectiveness of prophylactic use of intravenous (IV) dexmedetomidine VS ketamine and meperidine(as a control group) in prevention of shivering associated with intrathecal anesthesia in patients undergoing knee arthroscopy

Conditions

  • Shivering, Spinal Anesthesia

Interventions

DRUG

Dexmedetomidine

Patients will receive dexmedetomidine 0.5 mcg/kg diluted in 10 mL of NS given as IV infusion over 10 min before induction of spinal anesthesia

DRUG

Ketamine

Patient will will receive ketamine 0.5 mg/kg diluted in 10 mL of NS given as IV infusion over 10 min before induction of spinal anesthesia

DRUG

Meperidine

If the tested drug hasn't stopped shivering patient will receive 0.25 mg/kg meperidine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Essam Ez Abdelhakeem, Professor · Assiut University

  • Seham Mo Moeen, Professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-11-30
Completion
2024-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06082076 on ClinicalTrials.gov